Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.65% |
| Jun 30, 2025 | 9.02% |
| Mar 31, 2025 | 10.16% |
| Dec 31, 2024 | 14.43% |
| Sep 30, 2024 | 5.27% |
| Jun 30, 2024 | 11.61% |
| Mar 31, 2024 | -22.67% |
| Dec 31, 2023 | 15.53% |
| Sep 30, 2023 | 4.22% |
| Jun 30, 2023 | -12.54% |
| Mar 31, 2023 | -39.42% |
| Dec 31, 2022 | 5.12% |
| Sep 30, 2022 | -2.58% |
| Jun 30, 2022 | -16.26% |
| Mar 31, 2022 | -9.75% |
| Dec 31, 2021 | -13.17% |
| Sep 30, 2021 | 17.86% |
| Jun 30, 2021 | -46.46% |
| Mar 31, 2021 | -52.69% |
| Dec 31, 2020 | -79.54% |